4-(4-methoxyphenyl)-3,4-dihydrobenzo[h]quinolin-2(1H)-one | 64257-25-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-(4-methoxyphenyl)-3,4-dihydrobenzo[h]quinolin-2(1H)-one
• 英文别名: 4-(4-methoxy-phenyl)-3,4-dihydro-1H-benzo[h]quinolin-2-one；4-(4-methoxyphenyl)-3,4-dihydro-1H-benzo[h]quinolin-2-one
• CAS: 64257-25-6
• 化学式: C₂₀H₁₇NO₂
• 分子量: 303.36
• InChiKey: GFEBNMNHJHACLC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  丙二酸环(亚)异丙酯 、 (E)-N-(4-methoxybenzylidene)-1-naphthalenamine 以50%的产率得到
  参考文献：
  名称：

  STRODS YA. A.; LIELBRIEDIS I. EH.; NEJLAND O. YA., XIMIYA GETEROTSIKL. SOEDIN., 1977, HO 7, 977-979

  摘要：

  DOI：

文献信息

• Compounds, compositions and methods of inhibiting a-synuclein toxicity
  申请人：The Whitehead Institute for Biomedical Research

  公开号：EP2433634A2

  公开（公告）日：2012-03-28

  Compounds and compositions are provided for treatment or amelioration of one or more symptoms of a-synuclein toxicity, a-synuclein mediated diseases or diseases in which a-synuclein fibrils are a symptom or cause of the disease. In one embodiment, the compounds for use in the compositions and methods are heteroaryl acylguanidines, heteroarylhydrazones, dihydropyridones, heteroaryl and aryl styryl ketones, and heteroarylpyrazoles.

  提供的化合物和组合物用于治疗或改善a-突触核蛋白毒性、a-突触核蛋白介导的疾病或a-突触核蛋白纤维是症状或病因的疾病的一种或多种症状。在一个实施方案中，用于组合物和方法的化合物是杂芳基酰基胍、杂芳基肼、二氢吡啶酮、杂芳基和芳基苯乙烯基酮以及杂芳基吡唑。
• Highly Efficient Synthesis of 3,4-Dihydro-2(1H)-quinolinone Derivatives under Microwave Heating
  作者：Shu-Jiang Tu、Bo Jiang、Xiao-Tong Zhu、Qiu-Yun Li

  DOI：10.3987/com-12-12489

  日期：——

  A sequential three-component reaction of aromatic aldehydes with aromatic amine, and Meldrum's acid in EtOH under microwave irradiation has been developed. In this one-pot reaction, a series of 3,4-dihydro-2(1H)-quinolinone derivatives were synthesized with high chemical yields. The present green synthesis shows several advantages including operational simplicity and fast reaction rate, which makes it a useful and attractive process for library generation for drug discovery.
• US8440705B2
  申请人：——

  公开号：US8440705B2

  公开（公告）日：2013-05-14